Magnolia Vanegas
Magnolia Vanegas
Fundación Instituto de Inmunología de Colombia, Universidad del Rosario - Escuela de Medicina
Verified email at
Cited by
Cited by
Computational Prediction and Experimental Assessment of Secreted/Surface Proteins from Mycobacterium tuberculosis H37Rv
C Vizcaíno, D Restrepo-Montoya, D Rodríguez, LF Niño, M Ocampo, ...
PLoS computational biology 6 (6), e1000824, 2010
Splenectomised and spleen intact Aotus monkeys’ immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides
AY Sierra, CA Barrero, R Rodriguez, Y Silva, C Moncada, M Vanegas, ...
Vaccine 21 (27-30), 4133-4144, 2003
Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family
J García, H Curtidor, CG Pinzón, M Vanegas, A Moreno, ME Patarroyo
Vaccine 27 (30), 3953-3962, 2009
Serine repeat antigen peptides which bind specifically to red blood cells
A Puentes, J Garcia, R Vera, QR Lopez, M Urquiza, M Vanegas, ...
Parasitology international 49 (2), 105-117, 2000
Modified merozoite surface protein‐1 peptides with short alpha helical regions are associated with inducing protection against malaria
MH Torres, LM Salazar, M Vanegas, F Guzman, R Rodriguez, Y Silva, ...
European journal of biochemistry 270 (19), 3946-3952, 2003
IMPIPS: The Immune Protection-Inducing Protein Structure Concept in the Search for Steric-Electron and Topochemical Principles for Complete Fully-Protective …
ME Patarroyo, A Bermúdez, MP Alba, M Vanegas, A Moreno-Vranich, ...
PLoS One 10 (4), e0123249, 2015
Specific Interaction between Mycobacterium tuberculosis Lipoprotein‐derived Peptides and Target Cells Inhibits Mycobacterial Entry In Vitro
M Ocampo, H Curtidor, M Vanegas, MA Patarroyo, ME Patarroyo
Chemical biology & drug design 84 (6), 626-641, 2014
Characterisation of the Plasmodium vivax Pv38 antigen
A Mongui, DI Angel, C Guzman, M Vanegas, MA Patarroyo
Biochemical and biophysical research communications 376 (2), 326-330, 2008
Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: Potential TB vaccine candidate antigen
DP Cifuentes, M Ocampo, H Curtidor, M Vanegas, M Forero, ...
BMC microbiology 10, 1-12, 2010
Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine
M Ocampo, MA Patarroyo, M Vanegas, MP Alba, ME Patarroyo
Critical reviews in microbiology 40 (2), 117-145, 2014
Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells
JE García, A Puentes, H Curtidor, R Vera, L Rodriguez, J Valbuena, ...
Peptides 26 (7), 1133-1143, 2005
Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine
H Curtidor, M Vanegas, M P Alba, M E Patarroyo
Current medicinal chemistry 18 (29), 4470-4502, 2011
The Plasmodium vivax Pv41 surface protein: identification and characterization
DI Angel, A Mongui, J Ardila, M Vanegas, MA Patarroyo
Biochemical and biophysical research communications 377 (4), 1113-1117, 2008
Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically …
A Bermúdez, M Vanegas, ME Patarroyo
Vaccine 26 (52), 6908-6918, 2008
P. falciparum: merozoite surface protein-8 peptides bind specifically to human erythrocytes
A Puentes, J Garcıa, M Ocampo, L Rodrıguez, R Vera, H Curtidor, ...
Peptides 24 (7), 1015-1023, 2003
Peptides derived of Kunitz-type serine protease inhibitor as potential vaccine against experimental schistosomiasis
J Hernández-Goenaga, J López-Abán, AV Protasio, B Vicente Santiago, ...
Frontiers in immunology 10, 469865, 2019
Characterising Mycobacterium tuberculosis Rv1510c protein and determining its sequences that specifically bind to two target cell lines
R Vera-Bravo, E Torres, JJ Valbuena, M Ocampo, LE Rodríguez, ...
Biochemical and biophysical research communications 332 (3), 771-781, 2005
Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization
A Bermúdez, C Reyes, F Guzmán, M Vanegas, J Rosas, R Amador, ...
Vaccine 25 (22), 4487-4501, 2007
Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC− TCR complex determine protection against malaria
G Cifuentes, F Espejo, LE Vargas, C Parra, M Vanegas, ME Patarroyo
Biochemistry 43 (21), 6545-6553, 2004
Atomic evidence that modification of H-bonds established with amino acids critical for host-cell binding induces sterile immunity against malaria
ME Patarroyo, G Cifuentes, C Piraján, A Moreno-Vranich, M Vanegas
Biochemical and biophysical research communications 394 (3), 529-535, 2010
The system can't perform the operation now. Try again later.
Articles 1–20